Novo Nordisk's Earnings Beat Estimates on Surging Demand for Its Weight-Loss Drugs
Danish drugmaker Novo Nordisk saw revenue and profits jump year-over-year as demand for its weight loss drugs Ozempic and Wegovy surged.
( 18
min )